This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hatziapostolou, M. Articles by Tsichlis, P. N. Search for Related Content PubMed PubMed Citation Articles by Hatziapostolou, M. Articles by Tsichlis, P. N.

Proteinase-Activated Receptor-1–Triggered Activation of Tumor Progression Locus-2 Promotes Actin Cytoskeleton Reorganization and Cell Migration

Molecular Oncology Research Institute, Tufts-New England Medical Center, Boston, Massachusetts

Requests for reprints: Philip N. Tsichlis, Molecular Oncology Research Institute, Tufts-New England Medical Center, 750 Washington Street, #5609, Boston, MA 02111. Phone: 617-636-6111; Fax: 617-636-6127; E-mail: ptsichlis{at}tufts-nemc.org.

Key Words: Tpl2 • PAR1 • migration • stroma • tumor

Tumor progression locus 2 (Tpl2), a mitogen-activated protein kinase kinase kinase (MAP3K) that is activated by provirus insertion in retrovirus-induced rodent lymphomas and mammary adenocarcinomas, is known to transduce Toll-like receptor, interleukin 1, tumor necrosis factor , and CD40 signals and to play an important role in inflammation. Here we show that Tpl2 is also required for the transduction of cell migration and gene expression signals originating in the G-protein–coupled receptor proteinase-activated receptor 1 (PAR1). PAR1 signals transduced by Tpl2 activate Rac1 and focal adhesion kinase, and they are required for reorganization of the actin cytoskeleton and cell migration. PAR1 expressed in fibroblasts can be triggered by proteinases produced by tumor cells, and PAR1 expressed in tumor cells can be triggered by proteinases produced by fibroblasts. These data suggest that signals that regulate cell migration and gene expression flow between stromal and tumor cells in both directions and that Tpl2 plays a pivotal role in this process. [Cancer Res 2008;68(6):1851–61]

This article has been cited by other articles:

				W. T. Watford, B. D. Hissong, L. R. Durant, H. Yamane, L. M. Muul, Y. Kanno, C. M. Tato, H. L. Ramos, A. E. Berger, L. Mielke, et al. Tpl2 kinase regulates T cell interferon-{gamma} production and host resistance to Toxoplasma gondii J. Exp. Med., November 24, 2008; 205(12): 2803 - 2812. [Abstract] [Full Text] [PDF]